ASPIRO FDA Approval ANDA 216617

ANDA 216617

ASPIRO

FDA Drug Application

Application #216617

Application Sponsors

ANDA 216617ASPIRO

Marketing Status

Prescription001

Application Products

001SOLUTION;INTRAVENOUS1GM/100ML (10MG/ML)0ACETAMINOPHENACETAMINOPHEN

FDA Submissions

UNKNOWN; ORIG1AP2022-07-27STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAP

CDER Filings

ASPIRO
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 216617
            [companyName] => ASPIRO
            [docInserts] => ["",""]
            [products] => [{"drugName":"ACETAMINOPHEN","activeIngredients":"ACETAMINOPHEN","strength":"1GM\/100ML (10MG\/ML)","dosageForm":"SOLUTION;INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"07\/27\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-07-27
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.